Patents by Inventor Grith Skytte Olsen

Grith Skytte Olsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Acylated Insulin Analogues and Uses Thereof
    Publication number: 20210094999
    Abstract: The present invention relates to novel insulin analogues and derivatives thereof, such as acylated insulin analogues, and their pharmaceutical use, in particular in the treatment or prevention of medical conditions relating to diabetes, obesity and cardiovascular diseases.
    Type: Application
    Filed: November 5, 2020
    Publication date: April 1, 2021
    Inventors: Grith Skytte Olsen, Bo Falck Hansen, Lauge Schaeffer, Ingrid Pettersson, Rita Slaaby, Jakob Brandt
  • Acylated insulin analogues and uses thereof
    Patent number: 10919949
    Abstract: The present invention relates to novel insulin analogues and derivatives thereof, such as acylated insulin analogues, and their pharmaceutical use, in particular in the treatment or prevention of medical conditions relating to diabetes, obesity and cardiovascular diseases.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: February 16, 2021
    Assignee: Novo Nordisk A/S
    Inventors: Grith Skytte Olsen, Bo Falck Hansen, Lauge Schaeffer, Ingrid Pettersson, Rita Slaaby, Jakob Brandt
  • Novel Acylated Insulin Analogues and Uses Thereof
    Publication number: 20190194285
    Abstract: The present invention relates to novel insulin analogues and derivatives thereof, such as acylated insulin analogues, and their pharmaceutical use, in particular in the treatment or prevention of medical conditions relating to diabetes, obesity and cardiovascular diseases.
    Type: Application
    Filed: August 16, 2018
    Publication date: June 27, 2019
    Inventors: Grith Skytte Olsen, Bo Falck Hansen, Lauge Schaeffer, Ingrid Pettersson, Rita Slaaby, Jakob Brandt